Global benefit-risk comparison of venlafaxine/venlafaxine XR, selective serotonin reuptake inhibitors, and placebo
- 作者R. Entsuah; B. Gao
- 卷第11卷
- 文件大小142.40KB
- 发表时间2001
- DOI10.1016/s0924-977x(01)80155-3
同作者推荐
P4.012 Memantine treatment for mild to severeAlzheimer's disease: Clinical trials summaryP.N. Tariot; R.S. Doody; E.R. Peskind; H. Winblad; A. Stoeffler; H.J. Moebius; S.M. Grahams; S. McDonalds · 2004
P4.011 Functional benefit of memantine treatment inpatients with moderate to severe Alzheimer's diseaseY. Wirth; R.S. Doody; F.A. Schmitt; H.J. Moebius; A. Stoeffler · 2004
Neuro-radiological findings and the magnitude of cognitive benefit by memantine treatment. A subgroup analysis of two placebo-controlled clinical trials in vascular dementiaG. Wilcock; A. Stoeffler; K. Sahin; H.J. Moebius · 2000